Figure 1From: Breast cancer subtypes and survival in patients with brain metastasesKaplan-Meier survival curves according to triple receptor status (a) from recurrence to death of all patients (n = 126), (b) from brain metastasis to death of all patients (n = 126), (c) from recurrence to death, excluding patients who received trastuzumab after BM (n = 105), and (d) from brain metastasis to death, excluding patients who received trastuzumab after BM (n = 105).Back to article page